SEC Form 4 · accession 0001437749-16-035613
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Hemmeter
Officer — Chief Executive Officer
Period of report
Jul 21, 2016
Accepted (ET)
Jul 25, 2016 · 1:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy)F3 | $11.35 | Jul 21, 2016 | M | 150,000 | A | — | Jul 21, 2023 | Common Stock | 150,000 | 150,000 | D |
| Right to Buy Restricted Stock Unit (RSU)F2,F1 | — | Jul 21, 2016 | M | 50,000 | A | — | — | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock.
- F2The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
- F31/36 of the grant becomes exercisable on each monthly anniversary of the grant date.